|
 |
 |
 |
 |
Name:
Sector:
Chief Executive:
|
Senomyx
Healthcare
Kent Snyder
|
|
|
Summary:
|
Leader in the application of high-throughput screening technologies
to discovering new and improved proprietary flavor and fragrance
molecules for use in a wide range of consumer products.
|
|
|
Stage of Initial
Investment:
|
Seed/Early |
Liquidity:
|
IPO
(NASDAQ: SNMX)
|
|
|
|
|
|
|
|
 |
| |
4767 Nexus Centre Drive
San Diego, CA 92121
Phone: 858.646.8300
Fax: 858.404.0752 |
|
 |
|
|
|
